{"id":"W4286515998","doi":"10.1016/s0140-6736(22)01199-0","title":"Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Lundbeckfonden; Pfizer","keywords":"Dupilumab; Atopic dermatitis; Medicine; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002351052,0.002077553,0.003766174,0.0003675221,0.0005439244,0.001539476,0.0009668847,0.002375784,0.005996781],"category_scores_gemma":[0.002216309,0.0008150056,0.003241102,0.0003665757,0.001361281,0.001526427,0.0005066934,0.004055276,0.001149303],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009258249,"about_ca_system_score_gemma":0.0007866541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009991918,"about_ca_topic_score_gemma":0.002078952,"domain_scores_codex":[0.9990522,0.0004607984,0.00006221064,0.0001878228,0.0000734366,0.0001635042],"domain_scores_gemma":[0.9988717,0.0004023284,0.0002450385,0.00008395113,0.00007279534,0.0003242016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9879194,0.001619095,0.0003318778,0.0005557695,0.0009394008,0.00003205528,0.00004717787,0.0001262584,0.001451093,0.00005266411,0.0004367272,0.006488325],"study_design_scores_gemma":[0.9635512,0.03356832,0.001439176,0.00003021567,0.0005539681,0.00004182751,0.0000240473,0.0001905972,0.0001671721,0.00009329184,0.0003262381,0.00001405143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831052,0.01026759,0.0005163284,0.0007774309,0.0007642602,0.001706051,0.0008340135,0.0001025749,0.00192662],"genre_scores_gemma":[0.9897227,0.002894308,0.0008844095,0.001277543,0.0004938334,0.001678092,0.0007712401,0.00002495011,0.002252828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005996781,"threshold_uncertainty_score":0.02006125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03158100381799388,"score_gpt":0.3123571558196823,"score_spread":0.2807761520016884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}